Clinical False-Positive Drug Test Results
A confirmed positive drug test reassures all the parties involved in the drug testing process that the reported positive result is an analytical true positive and as such is evidence that the individual has been exposed to the drug. That individual may not be a drug abuser and may have a valid alternative explanation for the positive result. In this context, an analytical true positive result may be a clinical false positive. There are many causes other than illicit drug use which can produce positive analytical results. These include environmental exposure, ingestion of medications containing the drugs or medications which metabolize to the target drugs, and consumption of food products containing the drug. Additional laboratory tests and a thorough medical review will ascertain the source of the drug detected and eliminate misinterpreting a clinical false-positive result to implicate that individual as an illicit drug user.
KeywordsAmphetamine cocaine false positive GC-MS marijuana AQ1 opiate.
Unable to display preview. Download preview PDF.
- 1.Magnani B. Concentrations of compounds that produce positive results. In: Shaw L, Kwong T, eds. The Clinical Toxicology Laboratory, Contemporary Practice of Poisoning Evaluation. Washington, DC: AACC Press, 2001: 482–497.Google Scholar
- 2.Green KB, Isenschmid DS. Medical review officer inteiew officer interpretation of urine drug test results. In: Liu RH, Goldberger B, eds. Handbook of Workplace Drug Testing. Washington, DC: AACC Press, 1995: 321–354.Google Scholar
- 5.Cody JT. Important issues in testing of methamphetamine enantiomer ratios in urine by gas chromatography-mass spectrometry. In: Liu RH, Goldberger B, eds. Handbook of Workplace Drug Testing. Washington, DC: AACC Press, 1995: 239–288.Google Scholar
- 6.Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Medical Review Officer Manual for Federal Agency Workplace Drug Testing Programs.http://dwp.samhsa.gov/DrugTesting/Level_1_Pages/HHS%20MRO%20Manual%20(Effective%20November%201,%202004).aspx. Accessed 11/05/2006.Google Scholar
- 18.Huestis MA, Cone E. Drug test findings resulting from unconventional drug exposure. In: Liu RH, Goldberger B, eds. Handbook of Workplace Drug Testing. Washington, DC: AACC Press, 1995: 289–320.Google Scholar
- 29.ElSohly MA, Jones AB. Origin of morphine and codeine in biological fluids. In: Liu RH, Goldberger B, eds. Handbook of Workplace Drug Testing. Washington, DC: AACC Press, 1995: 225–238.Google Scholar
- 30.Jackson GF, Saddy JJ, Poklis A. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol 2003; 27: 449–452.Google Scholar
- 32.Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Federal Register Notice Changing the Opiate Testing Cutoff Concentrations (effective December 1, 1998). http://dwp.samhsa.gov/FedPgms/Files/FR_Notice_Opiate_Testing_Cutoff_Concentrations.aspx. Accessed 11/05/2006.Google Scholar